company background image
4183

EPS Bio Technology TPEX:4183 Stock Report

Last Price

NT$18.50

Market Cap

NT$440.3m

7D

3.6%

1Y

-7.7%

Updated

27 Jun, 2022

Data

Company Financials
4183 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends4/6

4183 Stock Overview

EPS Bio Technology Corp. manufactures and sells OEM/ODM glucose meters and strips primarily in Taiwan.

EPS Bio Technology Competitors

Price History & Performance

Summary of all time highs, changes and price drops for EPS Bio Technology
Historical stock prices
Current Share PriceNT$18.50
52 Week HighNT$20.90
52 Week LowNT$17.60
Beta0.65
1 Month Change0.82%
3 Month Change1.93%
1 Year Change-7.73%
3 Year Change3.93%
5 Year Change-23.08%
Change since IPO8.70%

Recent News & Updates

Shareholder Returns

4183TW Medical EquipmentTW Market
7D3.6%-0.3%-1.0%
1Y-7.7%-12.9%-11.3%

Return vs Industry: 4183 exceeded the TW Medical Equipment industry which returned -14.2% over the past year.

Return vs Market: 4183 exceeded the TW Market which returned -12.3% over the past year.

Price Volatility

Is 4183's price volatile compared to industry and market?
4183 volatility
4183 Average Weekly Movement4.2%
Medical Equipment Industry Average Movement4.8%
Market Average Movement4.7%
10% most volatile stocks in TW Market8.3%
10% least volatile stocks in TW Market2.3%

Stable Share Price: 4183 is not significantly more volatile than the rest of TW stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: 4183's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a127n/ahttps://epsbio.com

EPS Bio Technology Corp. manufactures and sells OEM/ODM glucose meters and strips primarily in Taiwan. It also provides diabetic self-monitoring blood glucose systems under the EASYMAX and MDT2 BLE name, as well as wearable, and NFC and Bluetooth connectivity blood glucose monitors. The company is headquartered in Hsinchu City, Taiwan.

EPS Bio Technology Fundamentals Summary

How do EPS Bio Technology's earnings and revenue compare to its market cap?
4183 fundamental statistics
Market CapNT$440.30m
Earnings (TTM)NT$26.50m
Revenue (TTM)NT$504.46m

16.6x

P/E Ratio

0.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
4183 income statement (TTM)
RevenueNT$504.46m
Cost of RevenueNT$380.07m
Gross ProfitNT$124.39m
Other ExpensesNT$97.89m
EarningsNT$26.50m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)1.11
Gross Margin24.66%
Net Profit Margin5.25%
Debt/Equity Ratio5.8%

How did 4183 perform over the long term?

See historical performance and comparison

Dividends

6.5%

Current Dividend Yield

106%

Payout Ratio

Does 4183 pay a reliable dividends?

See 4183 dividend history and benchmarks
When do you need to buy 4183 by to receive an upcoming dividend?
EPS Bio Technology dividend dates
Ex Dividend DateJul 12 2022
Dividend Pay DateAug 04 2022
Days until Ex dividend14 days
Days until Dividend pay date37 days

Does 4183 pay a reliable dividends?

See 4183 dividend history and benchmarks
We’ve recently updated our valuation analysis.

Valuation

Is 4183 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 4183?

Other financial metrics that can be useful for relative valuation.

4183 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.7x
Enterprise Value/EBITDA6.8x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does 4183's PE Ratio compare to its peers?

4183 PE Ratio vs Peers
The above table shows the PE ratio for 4183 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average19.8x
6543 Perfect Medical Industry
19xn/aNT$737.8m
3373 Radiant Innovation
20.2xn/aNT$1.0b
4735 AViTA
7.9xn/aNT$1.3b
4129 United Orthopedic
31.8xn/aNT$2.2b
4183 EPS Bio Technology
16.6xn/aNT$440.3m

Price-To-Earnings vs Peers: 4183 is good value based on its Price-To-Earnings Ratio (16.6x) compared to the peer average (19.8x).


Price to Earnings Ratio vs Industry

How does 4183's PE Ratio compare vs other companies in the TW Medical Equipment Industry?

Price-To-Earnings vs Industry: 4183 is good value based on its Price-To-Earnings Ratio (16.6x) compared to the TW Medical Equipment industry average (20.1x)


Price to Earnings Ratio vs Fair Ratio

What is 4183's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

4183 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio16.6x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 4183's Price-To-Earnings Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of 4183 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 4183 (NT$18.5) is trading below our estimate of fair value (NT$32.84)

Significantly Below Fair Value: 4183 is trading below fair value by more than 20%.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 4183's PEG Ratio to determine if it is good value.


Discover undervalued companies

Future Growth

How is EPS Bio Technology forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


17.0%

Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as EPS Bio Technology has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Discover growth companies

  • Examine whether EPS Bio Technology is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.

Past Performance

How has EPS Bio Technology performed over the past 5 years?

Past Performance Score

5/6

Past Performance Score 5/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


16.6%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 4183 has high quality earnings.

Growing Profit Margin: 4183's current net profit margins (5.3%) are higher than last year (4.8%).


Past Earnings Growth Analysis

Earnings Trend: 4183's earnings have grown by 16.6% per year over the past 5 years.

Accelerating Growth: 4183's earnings growth over the past year (20.1%) exceeds its 5-year average (16.6% per year).

Earnings vs Industry: 4183 earnings growth over the past year (20.1%) exceeded the Medical Equipment industry 13.7%.


Return on Equity

High ROE: 4183's Return on Equity (8.8%) is considered low.


Discover strong past performing companies

Financial Health

How is EPS Bio Technology's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: 4183's short term assets (NT$405.1M) exceed its short term liabilities (NT$162.9M).

Long Term Liabilities: 4183's short term assets (NT$405.1M) exceed its long term liabilities (NT$120.3M).


Debt to Equity History and Analysis

Debt Level: 4183 has more cash than its total debt.

Reducing Debt: 4183's debt to equity ratio has reduced from 11.2% to 5.8% over the past 5 years.

Debt Coverage: 4183's debt is well covered by operating cash flow (307.6%).

Interest Coverage: 4183's interest payments on its debt are well covered by EBIT (16.8x coverage).


Balance Sheet


Discover healthy companies

Dividend

What is EPS Bio Technology current dividend yield, its reliability and sustainability?

Dividend Score

3/6

Dividend Score 3/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


6.49%

Current Dividend Yield

Upcoming Dividend Payment

TodayJun 28 2022Ex Dividend DateJul 12 2022Dividend Pay DateAug 04 202223 days from Ex DividendBuy in the next 14 days to receive the upcoming dividend

Dividend Yield vs Market

Notable Dividend: 4183's dividend (6.49%) is higher than the bottom 25% of dividend payers in the TW market (2.54%).

High Dividend: 4183's dividend (6.49%) is in the top 25% of dividend payers in the TW market (6.35%)


Stability and Growth of Payments

Stable Dividend: 4183's dividend payments have been volatile in the past 10 years.

Growing Dividend: 4183's dividend payments have increased over the past 10 years.


Earnings Payout to Shareholders

Earnings Coverage: With its high payout ratio (106.1%), 4183's dividend payments are not well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its reasonable cash payout ratio (69.5%), 4183's dividend payments are covered by cash flows.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

EPS Bio Technology has no CEO, or we have no data on them.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

EPS Bio Technology Corp.'s employee growth, exchange listings and data sources


Key Information

  • Name: EPS Bio Technology Corp.
  • Ticker: 4183
  • Exchange: TPEX
  • Founded: NaN
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Implied Market Cap: NT$440.300m
  • Shares outstanding: 23.80m
  • Website: https://epsbio.com

Number of Employees


Location

  • EPS Bio Technology Corp.
  • No. 8, R&D Road III
  • Hsinchu Science Park
  • Hsinchu City
  • 30076
  • Taiwan

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/06/27 00:00
End of Day Share Price2022/06/27 00:00
Earnings2022/03/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.